Rapport Therapeutics CEO Abraham Ceesay Sells $64.4K of Stock
Abraham Ceesay, CEO, sold 2,210 shares of Rapport Therapeutics, Inc. at $29.16 a share, worth $64.4K in total on Oct 21, 2026. Shares held after the trade: 450,035 (-0.5%).
Rapport Therapeutics CEO Abraham Ceesay Sells $143K of Stock
Abraham Ceesay, CEO, sold 4,522 shares of Rapport Therapeutics, Inc. at $30.66 to $32.03 a share (average $31.68) in 2 transactions, worth $143K in total between Oct 6, 2026 and Oct 7, 2026. Shares held after the trade: 452,245 (-0.3%).
Rapport Therapeutics COO Cheryl Gault Sells $332K of Stock
Cheryl Gault, COO, sold 10,000 shares of Rapport Therapeutics, Inc. at $33.04 to $33.76 a share (average $33.19) in 2 transactions, worth $332K in total on Sep 30, 2026. Shares held after the trade: 139,914 (-1.5%).
Rapport Therapeutics CEO Abraham Ceesay Sells $76.2K of Stock
Abraham Ceesay, CEO, sold 1,952 shares of Rapport Therapeutics, Inc. at $39.05 a share, worth $76.2K in total on Sep 23, 2026. Shares held after the trade: 457,025 (-0.4%).